Therefore, ATP6AP1 may play a pivotal role in modulating tumor immunity and proliferation, underscoring its potential as a valuable biomarker and therapeutic target in colorectal cancer (CRC). The gene discussed is ATP6AP1; the disease is colorectal cancer.